Brian Tanquilut

Jefferies | Healthcare

Brian Tanquilut is an analyst from Jefferies specializing in the Healthcare sector. Ranked #1702 out of 4773 analysts, they have issued 19 stock ratings with a success rate of 83.72% and an average return of 21.75%.

With 19 ratings to date, Brian Tanquilut is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 83.72% and an average return of 21.75%, highlighting promising potential as their track record develops further.

#1702

Out of 4773

19

Total Ratings

+83.72%

Success Rate

+21.75%

Average Return

Recent Ratings Analysis

ODD

Sep 09, 2026

Target

$18.00

Current

$18.28

Performance

10.92%

Brian Tanquilut rated ODD as Hold on Sep 09, 2026, setting a price target of 18. Despite the Hold call, shares climbed 10.92% to 18.28, revealing unexpected momentum.

AHCO

Jul 21, 2026

Target

$13.00

Current

$6.06

Performance

-45.94%

On Jul 21, 2026, AHCO was given a Buy rating by Brian Tanquilut, with a target price of 13. Despite the Buy call, shares fell from 6.06 to 6.06, challenging the optimistic stance.

ACHC

Jun 03, 2026

Target

$30.00

Current

$28.36

Performance

10.22%

ACHC received a Buy rating from Brian Tanquilut on Jun 03, 2026, aiming for 30. Momentum has favored the Buy call, with shares climbing from 28.36 to 28.36, rewarding those who trusted the recommendation.

DOCS

May 14, 2026

Target

$19.00

Current

$25.58

Performance

42.03%

On May 14, 2026, Brian Tanquilut published a Hold outlook on DOCS, with a target of 19. The Hold call missed some of the bullish momentum as shares advanced toward 19.

GRDN

Mar 30, 2026

Target

$44.00

Current

$43.64

Performance

17.15%

Brian Tanquilut on Mar 30, 2026 assigned GRDN a Buy rating, with a price target of 44. The Buy call aligned well with market performance, producing a gain of 17.15%.

USPH

Mar 10, 2026

Target

$102.00

Current

$78.72

Performance

-1.59%

On Mar 10, 2026, Brian Tanquilut reaffirmed USPH with a Buy rating, targeting 102. Market indecision has kept the 102 target in a holding pattern.

EHAB

Feb 23, 2026

Target

$13.80

Current

$13.80

Performance

1.47%

EHAB was rated Hold by Brian Tanquilut on Feb 23, 2026, with a price objective of 13.8. Flat performance suggests the Hold view was reasonable.

THC

Feb 12, 2026

Target

$265.00

Current

$263.69

Performance

13.53%

On Feb 12, 2026, Brian Tanquilut initiated coverage on THC with a Buy rating and target of 265. The stock’s climb of 13.53% since the call highlights the foresight in the rating.

HCA

Jan 28, 2026

Target

$590.00

Current

$426.94

Performance

-13.09%

Brian Tanquilut issued a Buy recommendation for HCA on Jan 28, 2026, price target set at 590. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

COR

Jan 22, 2026

Target

$440.00

Current

$321.57

Performance

-8.77%

On Jan 22, 2026, COR was evaluated by Brian Tanquilut, who gave a Buy rating and target of 440. Investors saw limited payoff as shares fell short of the 440 target.

CHE

Jan 22, 2026

Target

$475.00

Current

$515.97

Performance

16.02%

Brian Tanquilut rated CHE as Hold on Jan 22, 2026, setting a price target of 475. Despite the Hold call, shares climbed 16.02% to 515.97, revealing unexpected momentum.

LMRI

Jan 05, 2026

Target

$23.00

Current

$11.49

Performance

-31.73%

On Jan 05, 2026, LMRI was given a Buy rating by Brian Tanquilut, with a target price of 23. Despite the Buy call, shares fell from 11.49 to 11.49, challenging the optimistic stance.

AVAH

Oct 28, 2025

Target

$12.50

Current

$14.08

Performance

43.53%

AVAH received a Buy rating from Brian Tanquilut on Oct 28, 2025, aiming for 12.5. Momentum has favored the Buy call, with shares climbing from 14.08 to 14.08, rewarding those who trusted the recommendation.

PNTG

Oct 24, 2025

Target

$30.00

Current

$39.20

Performance

55.31%

On Oct 24, 2025, Brian Tanquilut published a Buy outlook on PNTG, with a target of 30. Shares gained 55.31%, underscoring the accuracy of the bullish outlook toward 30.

MCK

Oct 14, 2025

Target

$900.00

Current

$881.51

Performance

12.74%

Brian Tanquilut on Oct 14, 2025 assigned MCK a Buy rating, with a price target of 900. The Buy call aligned well with market performance, producing a gain of 12.74%.

CYH

Jul 24, 2025

Target

$3.00

Current

$2.92

Performance

0.69%

On Jul 24, 2025, Brian Tanquilut reaffirmed CYH with a Hold rating, targeting 3. The neutral call matched muted market action of 0.69%.

CVS

Jun 30, 2025

Target

$80.00

Current

$94.66

Performance

37.23%

CVS was rated Buy by Brian Tanquilut on Jun 30, 2025, with a price objective of 80. A bullish response from the market helped close the gap of -14.66 to the target.

CAH

Feb 05, 2025

Target

$150.00

Current

$234.57

Performance

84.05%

On Feb 05, 2025, Brian Tanquilut initiated coverage on CAH with a Buy rating and target of 150. The stock’s climb of 84.05% since the call highlights the foresight in the rating.

OPCH

Jan 23, 2025

Target

$35.00

Current

$23.48

Performance

-21.73%

Brian Tanquilut issued a Buy recommendation for OPCH on Jan 23, 2025, price target set at 35. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

RDNT

Jan 15, 2025

Target

$80.00

Current

$75.49

Performance

22.27%

On Jan 15, 2025, RDNT was evaluated by Brian Tanquilut, who gave a Buy rating and target of 80. This case illustrates how a timely bullish rating can translate into tangible gains of 22.27%.

LH

Dec 10, 2024

Target

$275.00

Current

$311.54

Performance

32.83%

Brian Tanquilut rated LH as Buy on Dec 10, 2024, setting a price target of 275. The call has proven timely, with shares rising 32.83% toward the price target of 275.

BKD

Oct 16, 2024

Target

$8.00

Current

$12.14

Performance

81.74%

On Oct 16, 2024, BKD was given a Buy rating by Brian Tanquilut, with a target price of 8. The stock rallied 81.74% after the rating, narrowing the gap to the target of 8 and validating the bullish stance.

MODV

Sep 13, 2024

Target

$14.00

Current

$0.43

Performance

-96.94%

MODV received a Hold rating from Brian Tanquilut on Sep 13, 2024, aiming for 14. The Hold stance proved prudent, with the market softening by 96.94%.

Frequency Asked Questions

Who is Brian Tanquilut?

Brian Tanquilut is an analyst from Jefferies specializing in the Healthcare sector.

What is Brian Tanquilut's success rate?

Brian Tanquilut currently has a success rate of +83.72%.

How many ratings has Brian Tanquilut issued?

Brian Tanquilut has issued 19 stock ratings so far.

What is the average return of Brian Tanquilut's calls?

Their stock ratings have generated an average return of +21.75%.

What is Brian Tanquilut's ranking?

Brian Tanquilut is ranked #1702 out of 4773 analysts.

What types of ratings does Brian Tanquilut give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Brian Tanquilut?

You can follow Brian Tanquilut by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Brian Tanquilut?

Their latest rating was a Hold on ODD issued on 2026-09-09.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep